Liquidity and Going Concern - Additional Information (Detail) - USD ($) |
Jul. 31, 2017 |
Jun. 30, 2017 |
Dec. 31, 2016 |
---|---|---|---|
Liquidity and Going Concern [Line Items] | |||
Cash | $ 50,325,193 | $ 29,355,528 | |
Subsequent Event [Member] | AstraZeneca [Member] | |||
Liquidity and Going Concern [Line Items] | |||
Amount funded by collaborative partner | $ 45,000,000 |
X | ||||||||||
- Definition Liquidity and going concern. No definition available.
|
X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|